Document Detail


Does self-monitoring of blood glucose levels improve dietary compliance for obese patients with type II diabetes?
MedLine Citation:
PMID:  3535493     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Self-monitoring of blood glucose levels is currently being recommended for obese patients with type II diabetes to improve weight loss and glycemic control. To determine whether self-monitoring of blood glucose levels improves dietary compliance in these patients, 50 obese patients with type II diabetes were randomly assigned either to a standard behavioral weight control program or to a weight control program that included self-monitoring of blood glucose levels and focused on the weight-blood glucose relationship. Both groups lost significant amounts of weight and maintained their losses for at least one year; reductions in medication could be made for 70 percent of patients. These data suggest that the behavioral weight control used in this study may be of benefit to patients with type II diabetes. However, there was no evidence that the addition of self-monitoring of blood glucose levels to the treatment program improved the outcome in terms of weight loss, reduction in medication, dietary compliance, or mood state.
Authors:
R R Wing; L H Epstein; M P Nowalk; N Scott; R Koeske; S Hagg
Related Documents :
18963203 - Can blood glucose self-monitoring improve treatment outcomes in type 2 diabetes?
6316003 - Diagnostic monitoring of plasma levels of glucose and insulin during surgery for insuli...
10389853 - Antibodies to oxidized ldl predict coronary artery disease in type 1 diabetes: a nested...
Publication Detail:
Type:  Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, U.S. Gov't, P.H.S.    
Journal Detail:
Title:  The American journal of medicine     Volume:  81     ISSN:  0002-9343     ISO Abbreviation:  Am. J. Med.     Publication Date:  1986 Nov 
Date Detail:
Created Date:  1986-12-04     Completed Date:  1986-12-04     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  0267200     Medline TA:  Am J Med     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  830-6     Citation Subset:  AIM; IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Affect
Behavior Therapy
Blood Glucose / analysis*
Body Weight
Clinical Trials as Topic
Diabetes Mellitus, Type 2 / complications,  diet therapy*
Female
Habits
Hemoglobin A, Glycosylated / analysis
Humans
Insulin / administration & dosage
Male
Middle Aged
Obesity / complications*
Patient Compliance
Random Allocation
Self Care*
Grant Support
ID/Acronym/Agency:
AM-29757-04/AM/NIADDK NIH HHS
Chemical
Reg. No./Substance:
0/Blood Glucose; 0/Hemoglobin A, Glycosylated; 11061-68-0/Insulin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Prevalence of sensitivity to sulfiting agents in asthmatic patients.
Next Document:  Non-insulin-dependent diabetes in older patients. Complications and risk factors.